PlainRecalls
FDA Drug Moderate Class II Terminated

Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05

Reported: April 3, 2019 Initiated: March 19, 2019 #D-1056-2019

Product Description

Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05

Reason for Recall

cGMP Deviations

Details

Recalling Firm
Allergan Sales, LLC
Units Affected
72 bottles
Distribution
TN only
Location
Waco, TX

Frequently Asked Questions

What product was recalled?
Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05. Recalled by Allergan Sales, LLC. Units affected: 72 bottles.
Why was this product recalled?
cGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on April 3, 2019. Severity: Moderate. Recall number: D-1056-2019.